22 results on '"Gallina, Filippo Tommaso"'
Search Results
2. Pathological T3 Non-Small Cell Lung Cancer with satellite nodules: Number or size, what does matter?
- Author
-
Bertoglio, Pietro, Gallina, Filippo Tommaso, Aprile, Vittorio, Minervini, Fabrizio, Tajè, Riccardo, La Porta, Marilina, Lenzini, Alessandra, Ambrosi, Francesca, Kestenholz, Peter, Lucchi, Marco, Facciolo, Francesco, and Solli, Piergiorgio
- Published
- 2024
- Full Text
- View/download PDF
3. Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials
- Author
-
Marinelli, Daniele, Gallina, Filippo Tommaso, Pannunzio, Sergio, Di Civita, Mattia Alberto, Torchia, Andrea, Giusti, Raffaele, Gelibter, Alain Jonathan, Roberto, Michela, Verrico, Monica, Melis, Enrico, Tajè, Riccardo, Cecere, Fabiana Letizia, Landi, Lorenza, Nisticò, Paola, Porciello, Nicla, Occhipinti, Mario, Brambilla, Marta, Forde, Patrick M., Liu, Stephen V., Botticelli, Andrea, Novello, Silvia, Ciliberto, Gennaro, Cortesi, Enrico, Facciolo, Francesco, Cappuzzo, Federico, and Santini, Daniele
- Published
- 2023
- Full Text
- View/download PDF
4. Robotic thymectomy in thymic tumours: a multicentre, nation-wide study.
- Author
-
Comacchio, Giovanni Maria, Schiavon, Marco, Zirafa, Carmelina Cristina, Palma, Angela De, Scaramuzzi, Roberto, Meacci, Elisa, Bongiolatti, Stefano, Monaci, Nicola, Lyberis, Paraskevas, Novellis, Pierluigi, Brandolini, Jury, Parini, Sara, Ricciardi, Sara, D'Andrilli, Antonio, Bottoni, Edoardo, Gallina, Filippo Tommaso, Marino, Maria Carlotta, Lorenzoni, Giulia, Francavilla, Andrea, and Rendina, Erino Angelo
- Subjects
THYMECTOMY ,MYASTHENIA gravis ,SURGICAL complications ,TUMORS ,ROBOTICS ,DEMOGRAPHIC characteristics - Abstract
OBJECTIVES Robotic thymectomy has been suggested and considered technically feasible for thymic tumours. However, because of small-sample series and the lack of data on long-term results, controversies still exist on surgical and oncological results with this approach. We performed a large national multicentre study sought to evaluate the early and long-term outcomes after robot-assisted thoracoscopic thymectomy in thymic epithelial tumours. METHODS All patients with thymic epithelial tumours operated through a robotic thoracoscopic approach between 2002 and 2022 from 15 Italian centres were enrolled. Demographic characteristics, clinical, intraoperative, postoperative, pathological and follow-up data were retrospectively collected and reviewed. RESULTS There were 669 patients (307 men and 362 women), 312 (46.6%) of whom had associated myasthenia gravis. Complete thymectomy was performed in 657 (98%) cases and in 57 (8.5%) patients resection of other structures was necessary, with a R0 resection in all but 9 patients (98.6%). Twenty-three patients (3.4%) needed open conversion, but no perioperative mortality occurred. Fifty-one patients (7.7%) had postoperative complications. The median diameter of tumour resected was 4 cm (interquartile range 3–5.5 cm), and Masaoka stage was stage I in 39.8% of patients, stage II in 56.1%, stage III in 3.5% and stage IV in 0.6%. Thymoma was observed in 90.2% of patients while thymic carcinoma occurred in 2.8% of cases. At the end of the follow-up, only 2 patients died for tumour-related causes. Five- and ten-year recurrence rates were 7.4% and 8.3%, respectively. CONCLUSIONS Through the largest collection of robotic thymectomy for thymic epithelial tumours we demonstrated that robot-enhanced thoracoscopic thymectomy is a technically sound and safe procedure with a low complication rate and optimal oncological outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Ergonomic Assessment of Robotic versus Thoracoscopic Thymectomy.
- Author
-
Taje, Riccardo, Peer, Michael, Gallina, Filippo Tommaso, Ambrogi, Vincenzo, Sharbel, Azzam, Melis, Enrico, Elia, Stefano, Idit, Matot, Facciolo, Francesco, Patirelis, Alexandro, Sorge, Roberto, and Pompeo, Eugenio
- Subjects
THYMECTOMY ,CHEST endoscopic surgery ,SURGICAL complications ,PROPENSITY score matching ,SURGICAL robots ,ROBOTICS - Abstract
Introduction: Robotic and thoracoscopic surgery are being increasingly adopted as minimally invasive alternatives to open sternotomy for complete thymectomy. The superior maneuverability range and three-dimensional magnified vision are potential ergonomical advantages of robotic surgery. To compare the ergonomic characteristics of robotic versus thoracoscopic thymectomy, a previously developed scoring system based on impartial findings was employed. The relationship between ergonomic scores and perioperative endpoints was also analyzed. Methods: Perioperative data of patients undergoing robotic or thoracoscopic complete thymectomy between January 2014 and December 2022 at three institutions were retrospectively retrieved. Surgical procedures were divided into four standardized surgical steps: lower-horns, upper-horns, thymic veins and peri-thymic fat dissection. Three ergonomic domains including maneuverability, exposure and instrumentation were scored as excellent(score-3), satisfactory(score-2) and unsatisfactory(score-1) by three independent reviewers. Propensity score matching (2:1) was performed, including anterior mediastinal tumors only. The primary endpoint was the total maneuverability score. Secondary endpoints included the other ergonomic domain scores, intraoperative adverse events, conversion to sternotomy, operative time, post-operative complications and residual disease. Results: A total of 68 robotic and 34 thoracoscopic thymectomies were included after propensity score matching. The robotic group had a higher total maneuverability score (p = 0.039), particularly in the peri-thymic fat dissection (p = 0.003) and peri-thymic fat exposure score (p = 0.027). Moreover, the robotic group had lower intraoperative adverse events (p = 0.02). No differences were found in residual disease. Conclusions: Robotic thymectomy has shown better ergonomic maneuverability compared to thoracoscopy, leading to fewer intraoperative adverse events and comparable early oncological results. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. National Multicenter Study on the Comparison of Robotic and Open Thymectomy for Thymic Neoplasms in Myasthenic Patients: Surgical, Neurological and Oncological Outcomes.
- Author
-
Sicolo, Elisa, Zirafa, Carmelina Cristina, Romano, Gaetano, Brandolini, Jury, De Palma, Angela, Bongiolatti, Stefano, Gallina, Filippo Tommaso, Ricciardi, Sara, Maestri, Michelangelo, Guida, Melania, Morganti, Riccardo, Carleo, Graziana, Mugnaini, Giovanni, Tajè, Riccardo, Calabró, Fabrizia, Lenzini, Alessandra, Davini, Federico, Cardillo, Giuseppe, Facciolo, Francesco, and Voltolini, Luca
- Subjects
EVALUATION of medical care ,LENGTH of stay in hospitals ,RESEARCH ,THYMUS tumors ,MYASTHENIA gravis ,SURGICAL robots ,SURGICAL complications ,CANCER patients ,HOSPITAL care ,DESCRIPTIVE statistics - Abstract
Simple Summary: Extended thymectomy is the gold standard in the treatment of patients with thymic neoplasm and affected by myasthenia gravis. For a long time, the traditional approach has been sternotomy, though the application of minimally invasive techniques has spread in recent decades. Several authors have demonstrated the safety and feasibility of minimally invasive thymectomy. This multicenter study aims to compare the outcomes of robotic and open thymectomy in myasthenic patients affected by thymic tumors. Short-term and long-term results were presented, showing how the robotic approach can be considered comparable to open surgery in terms of oncological radicality and the improvement of myasthenic symptomatology, with associated faster recovery. Thymectomy is the gold standard in the treatment of thymic neoplasm and plays a key role in the therapeutic path of myasthenia gravis. For years, sternotomy has been the traditional approach for removing anterior mediastinal lesions, although the robotic thymectomy is now widely performed. The literature is still lacking in papers comparing the two approaches and evaluating long-term oncological and neurological outcomes. This study aims to analyze the postoperative results of open and robotic thymectomy for thymic neoplasms in myasthenic patients. Surgical, oncological and neurological data of myasthenic patients affected by thymic neoplasms and surgically treated with extended thymectomy, both with the open and the robotic approach, in six Italian Thoracic Centers between 2011 and 2021 were evaluated. A total of 213 patients were enrolled in the study: 110 (51.6%) were treated with the open approach, and 103 (48.4%) were treated with robotic surgery. The open surgery, compared with the robotic, presented a shorter operating time (p < 0.001), a higher number of postoperative complications (p = 0.038) and longer postoperative hospitalization (p = 0.006). No other differences were observed in terms of surgical, oncological or neurological outcomes. The robotic approach can be considered safe and feasible, comparable to the open technique, in terms of surgical, oncological and neurological outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC.
- Author
-
Gallina, Filippo Tommaso, Marinelli, Daniele, Tajè, Riccardo, Forcella, Daniele, Alessandrini, Gabriele, Cecere, Fabiana Letizia, Fusco, Francesca, Visca, Paolo, Sperduti, Isabella, Ambrogi, Vincenzo, Cappuzzo, Federico, Melis, Enrico, and Facciolo, Francesco
- Subjects
LYMPHADENECTOMY ,FACTOR analysis ,NON-small-cell lung carcinoma ,NEOADJUVANT chemotherapy ,METASTASIS ,LYMPH nodes - Abstract
Background: Despite notable advances made in preoperative staging, unexpected nodal metastases after surgery are still significantly detected. In this study we aim to analyze the upstaging rate in patients with clinical stage I NSCLC without evidence of nodal disease in the preoperative staging who underwent lobectomy and radical lymphadenectomy. Methods: Patients who underwent lobectomy and systematic lymphadenectomy for clinical stage INSCLCwere evaluated. Exclusion criteria included the neoadjuvant treatment, incomplete resection and no adherence to preoperative guidelines. Results: A total of 297 patients were included in the study. 159 patients were female, and the median age was 68 (61 - 73). The variables that showed a significant correlation with the upstaging rate at the univariate analysis were the number of resected lymph nodes and micropapillar/solid adenocar-cinoma subtype. This result was confirmed in the multivariate analysis with a OR= 2.545 (95%CI 1.136-5.701; p=0.02) for the number of resected lymph nodes and a OR=2.717 (95%CI 1.256-5.875; p=0.01) for the high-grade pattern of adenocarcinoma. Conclusion: Our results showed that in a homogeneous cohort of patients with clinical stage I NSCLC, the number of resected lymph nodes and the histological subtype of adenocarcinoma can significantly be associated with nodal metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Robotic Lobectomy without Complete Fissure for Non-Small Cell Lung Cancer: Technical Aspects and Perioperative Outcomes of the Tunnel Technique.
- Author
-
Gallina, Filippo Tommaso, Forcella, Daniele, Melis, Enrico, and Facciolo, Francesco
- Subjects
- *
LOBECTOMY (Lung surgery) , *NON-small-cell lung carcinoma , *LYMPHADENECTOMY , *ROBOTICS , *SURGICAL robots - Abstract
Even though the use of the "fissure-last" technique in mini-invasive lobectomy with the fissureless condition is well accepted, in terms of perioperative outcomes, controversies still surround the hilar lymph node dissection. In this article, we reported a description of the robotic "tunnel technique" approach in the right upper lobectomy in the absence of a defined fissure. We then compared the short terms outcomes of 30 consecutive cases treated using this technique, with 30 patients treated using the "fissure last" VATS approach in the same institution, before the start of the robotic surgery program. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomy.
- Author
-
Gallina, Filippo Tommaso, Melis, Enrico, Bertolaccini, Luca, Spaggiari, Lorenzo, Rocca, Michele, Donati, Davide Maria, Chiappetta, Marco, Margaritora, Stefano, Bertoglio, Pietro, Solli, Piergiorgio, Mammana, Marco, Rea, Federico, Onesti, Elisa Concetta, Ferraresi, Virginia, Sperduti, Isabella, Ciliberto, Gennaro, and Facciolo, Francesco
- Published
- 2023
- Full Text
- View/download PDF
10. Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients.
- Author
-
Gallina, Filippo Tommaso, Tajè, Riccardo, Forcella, Daniele, Gennari, Valeria, Visca, Paolo, Pierconti, Federico, Coccia, Cecilia, Cappuzzo, Federico, Sperduti, Isabella, Facciolo, Francesco, and Melis, Enrico
- Subjects
LOBECTOMY (Lung surgery) ,NON-small-cell lung carcinoma ,OLDER patients ,CANCER patients ,MINIMALLY invasive procedures ,FORCED expiratory volume - Abstract
Introduction: Minimally invasive surgery has become the standard for the early-stage non-small cell lung cancer (NSCLC). The appropriateness of the kind of lung resection for the elderly patients is still debated. Methods: We retrospectively reviewed patients with older than 75 years who underwent robotic lobectomy between May 2016 to June 2022. We selected 103 patients who met the inclusion criteria of the study. The preoperative cardiorespiratory functional evaluations were collected, and the risk of postoperative complications was calculated according to the Charlson Comorbidity Index, the American College of Surgery surgical risk calculator (ACS-NSQIP), EVAD score, and American Society of Anesthesiology (ASA) score. The patients were divided in two groups according to the presence of postoperative complications. Results: Forty-three patients were female, and 72.8% of the total population were former or active smokers. Thirty-five patients reported postoperative complications. The analysis of the two groups showed that the predicted postoperative forced expiratory volumes in the first second (FEV1) and forced vital capacity (FVC) were significantly lower in patients presenting postoperative complications (p=0.04). Moreover, the upstaging rate and the unexpected nodal metastases were higher in the postoperative complication groups. Conclusion: Robotic-assisted lobectomy for early-stage lung cancer is a safe and feasible approach in selected elderly patients. The factors that could predict the complication rate was the predicted postoperative FEV1 and the nodal disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.
- Author
-
Gallina, Filippo Tommaso, Balzano, Vittoria, Porciello, Nicla, Tajè, Riccardo, Forcella, Daniele, Melis, Enrico, Letizia Cecere, Fabiana, Fusco, Francesca, Buglioni, Simonetta, Visca, Paolo, Nisticò, Paola, Cappuzzo, Federico, and Spicer, Jonathan
- Subjects
- *
PROGRAMMED death-ligand 1 , *NON-small-cell lung carcinoma - Published
- 2024
- Full Text
- View/download PDF
12. Transesophageal Endoscopic Ultrasound Fine Needle Biopsy for the Diagnosis of Mediastinal Masses: A Retrospective Real-World Analysis.
- Author
-
Assisi, Daniela, Gallina, Filippo Tommaso, Forcella, Daniele, Tajè, Riccardo, Melis, Enrico, Visca, Paolo, Pierconti, Federico, Venti, Emanuela, and Facciolo, Francesco
- Subjects
- *
ENDOSCOPIC ultrasonography , *NEEDLE biopsy , *DIAGNOSIS , *ADRENAL glands ,MEDIASTINAL tumors - Abstract
Background: Endoscopic ultrasound (EUS) plays an important role in the diagnosis and staging of thoracic disease. Our report studies the diagnostic performance and clinical impact of EUS fine needle aspiration (FNA) in a homogenous cohort of patients according to the distribution of the enlarged MLNs or pulmonary masses. Methods: We retrospectively reviewed the diagnostic performance of 211 EUS-FNA in 200 consecutive patients with enlarged or PET-positive MLNs and para-mediastinal masses who were referred to our oncological center between January 2019 and May 2020. Results: The overall sensitivity of EUS-FNA was 85% with a corresponding negative predictive value (NPV) of 56% and an accuracy of 87.5%. The sensitivity and accuracy in patients with abnormal MLNs were 81.1% and 84.4%, respectively. In those with para-mediastinal masses, sensitivity and accuracy were 96.4% and 96.8%. The accuracy for both masses and lymph nodes was 100%, and in the LAG (left adrenal gland), it was 66.6%. Conclusions: Our results show that, in patients with suspected mediastinal masses, EUS-FNA is an accurate technique to evaluate all reachable mediastinal nodal stations, including station 5. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?
- Author
-
Gallina, Filippo Tommaso, Cecere, Fabiana Letizia, Tajè, Riccardo, Forcella, Daniele, Melis, Enrico, Cappuzzo, Federico, and Facciolo, Francesco
- Subjects
- *
NON-small-cell lung carcinoma , *LUNGS , *ADENOCARCINOMA - Abstract
A recent study published in Surgery Today presents a nomogram developed by Karita et al. for predicting occult lymph node metastasis in non-small-cell lung cancer (NSCLC) patients. The nomogram incorporates preoperative computed tomography (CT) findings, including volume-doubling time, to provide clinicians with a practical tool for treatment planning and decision-making. The study highlights the potential clinical significance of the nomogram, which effectively integrates factors associated with occult lymph node metastasis. While the study focuses on imaging-based prediction, the authors acknowledge the importance of molecular profiling in optimizing patient care and personalized treatment strategies. The study suggests that the nomogram could be further strengthened by incorporating insights from molecular profiling. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
14. Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer.
- Author
-
Gallina, Filippo Tommaso, Tajè, Riccardo, Forcella, Daniele, Corzani, Felicita, Cerasoli, Virna, Visca, Paolo, Coccia, Cecilia, Pierconti, Federico, Sperduti, Isabella, Cecere, Fabiana Letizia, Cappuzzo, Federico, Melis, Enrico, and Facciolo, Francesco
- Subjects
- *
LOBECTOMY (Lung surgery) , *NON-small-cell lung carcinoma , *LYMPHADENECTOMY , *SMOKING , *SURGICAL robots - Abstract
Background: While the thoracotomy approach was considered the gold standard until two decades ago, robotic surgery has increasingly strengthened its role in lung cancer treatment, improving patients' peri-operative outcomes. In this study, we report our experience in robotic lobectomy for early-stage non-small cell lung cancer, with particular attention to oncological outcomes and nodal upstaging rate. Methods: We retrospectively reviewed patients who underwent lobectomy and radical lymphadenectomy at our Institute between 2016 and 2020. We selected 299 patients who met the inclusion criteria of the study. We analyzed the demographic features of the groups as well as their nodal upstaging rate after pathological examination. Then, we analyzed disease-free and overall survival of the entire enrolled patient population and we compared the same oncological outcomes in the upstaging and the non-upstaging group. Results: A total of 299 patients who underwent robotic lobectomy were enrolled. After surgery, 55 patients reported nodal hilar or mediastinal upstaging. The 3-year overall survival of the entire population was 82.8%. The upstaging group and the non-upstaging group were homogeneous for age, gender, smoking habits, clinical stage, tumor site, tumor histology. The non-upstaging group had better OS (p = 0.004) and DFS (p < 0.0001). Conclusion: Our results show that robotic surgery is a safe and feasible approach for the treatment of early-stage NSCLC, especially for its accuracy in mediastinal lymphadenectomy. The oncological outcomes were encouraging and consistent with previous findings. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review.
- Author
-
Gallina, Filippo Tommaso, Bertolaccini, Luca, Forcella, Daniele, Mohamed, Shehab, Ceddia, Serena, Melis, Enrico, Fusco, Francesca, Bardoni, Claudia, Marinelli, Daniele, Buglioni, Simonetta, Visca, Paolo, Cappuzzo, Federico, Spaggiari, Lorenzo, and Facciolo, Francesco
- Subjects
- *
LUNG cancer prognosis , *ONLINE information services , *MEDICAL databases , *GENETIC mutation , *MEDICAL information storage & retrieval systems , *SYSTEMATIC reviews , *MOLECULAR pathology , *SURVIVAL analysis (Biometry) , *DESCRIPTIVE statistics , *TUMOR markers , *MEDLINE , *PROGRESSION-free survival - Abstract
Simple Summary: In the last few years, the treatment of advanced NSCLC has radically changed after the development of new drugs against specific molecular targets. Moreover, multiple tumour biopsies have become mandatory in order to better select the appropriate targeted therapy. Molecular analysis using NGS in the early stage of NSCLC is still relatively widespread. The recent clinical trials that use targeted therapies in neoadjuvant and adjuvant settings also require molecular characterisation for early-stage patients. Due to the widespread use of molecular analysis in patients with early-stage NSCLC, the prognostic role of molecular biomarkers needs to be fully understood. This paper aimed to review the most recent studies associating the molecular expressions of early-stage NSCLC with survival. Next-generation sequencing has become a cornerstone in clinical oncology practice and is recommended for the appropriate use of tailored therapies in NSCLC. While NGS has already been standardised in advanced-stage NSCLC, its use is still uncommon in the early stages. The recent approval of Osimertinib for resected EGFR-mutated NSCLC in an adjuvant setting has launched the hypothesis that other targeted therapies used in metastatic patients can also lead to improved early-stage outcomes of NSCLC. The impact of molecular biomarkers on the prognosis of patients undergoing radical surgery for NSCLC is still unclear. Notably, the heterogeneous populations included in the studies that analysed surgical patients could be the main reason for these results. In this review, we report the most important studies that analysed the impact of principal molecular biomarkers on the survival outcomes of patients who underwent radical surgery for NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes.
- Author
-
Melis, Enrico, Gallo, Enzo, di Martino, Simona, Gallina, Filippo Tommaso, Laquintana, Valentina, Casini, Beatrice, Visca, Paolo, Ganci, Federica, Alessandrini, Gabriele, Caterino, Mauro, Cecere, Fabiana Letizia, Mandoj, Chiara, Papadantonakis, Arianna, De Bello, Nicoletta, Lattanzio, Rossano, Palmieri, Giovannella, Garassino, Marina Chiara, Girard, Nicolas, Conti, Laura, and Blandino, Giovanni
- Subjects
EPITHELIAL tumors ,TRANSLATIONAL research ,THYMUS tumors ,CANCER invasiveness ,EPITHELIAL cells ,AUTOIMMUNE diseases - Abstract
Among the group of thymic epithelial tumors (TET), thymomas often show either uncertain or explicit malignant biological behavior, local invasiveness, and intrathoracic relapse and are often difficult to manage. From the initial stages, thymic carcinomas tend to show aggressive behavior and extrathoracic spread. Moreover, the interplay of epithelial cells and thymocytes in thymomas causes complex immune derangement and related systemic autoimmune diseases. Due to their rare occurrence and to the limited funding opportunities available for rare tumors, it is challenging to make advances in clinical and translational research in TET. The authors of this paper are all members of a multidisciplinary clinical and research thoracic tumor team. Strong input was given to the team by long-standing expertise in TET in the Pathology Department. In addition, thanks to the collaboration between research units at our Institute as well as to national collaborations, over the last 10 years we were able to perform several tissue-based research studies. The most recent studies focused on microRNA and on functional studies on the thymic carcinoma cell line 1889c. The recent implementation of our biobank now provides us with a new tool for networking collaborative research activities. Moreover, the participation in a worldwide community such as ITMIG (International Thymic Malignancy Interest Group) has allowed us to significantly contribute toward fundamental projects/research both in tissue-based studies (The Cancer Genome Atlas) and in clinical studies (TNM staging of TET). Our achievements derive from constant commitment and long-standing experience in diagnosis and research in TET. New perspectives opened up due to the establishment of national [the Italian Collaborative Group for ThYmic MalignanciEs (TYME)] and European reference networks such as EURACAN, for an empowered joint clinical action in adult solid rare tumors. The challenge we face still lies in the advancement of clinical and basic science in thymic epithelial malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. CT‐guided indocyanine green and lipiodol marking of ground glass opacity before robotic‐assisted lung resection.
- Author
-
Gallina, Filippo Tommaso, Cappelli, Federico, Forcella, Daniele, Tajè, Riccardo, Bruschi, Mattia, Gennari, Valeria, Vallati, Giulio Eugenio, Facciolo, Francesco, and Melis, Enrico
- Published
- 2023
- Full Text
- View/download PDF
18. Primary lung adenocarcinoma of the azygos lobe invading the azygos arch treated with robotic surgery.
- Author
-
Gallina, Filippo Tommaso, Melis, Enrico, Forcella, Daniele, Tajè, Riccardo, Gennari, Valeria, and Facciolo, Francesco
- Subjects
- *
SURGICAL robots , *LUNGS , *ADENOCARCINOMA - Published
- 2023
- Full Text
- View/download PDF
19. ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.
- Author
-
Gallina, Filippo Tommaso, Tajè, Riccardo, Letizia Cecere, Fabiana, Forcella, Daniele, Landi, Lorenza, Minuti, Gabriele, Fusco, Francesca, Buglioni, Simonetta, Visca, Paolo, Melis, Enrico, Sperduti, Isabella, Ciliberto, Gennaro, Cappuzzo, Federico, and Facciolo, Francesco
- Subjects
- *
LYMPHADENECTOMY , *SURGERY , *NEOADJUVANT chemotherapy , *METASTASIS , *LUNGS , *ADENOCARCINOMA - Abstract
Despite notable advances made in preoperative staging, unexpected nodal metastases after surgery are still significantly detected. Given the promising role of neoadjuvant targeted treatments, the definition of novel predictive factors of nodal metastases is an extremely important issue. In this study we aim to analyze the upstaging rate in patients with early stage NSCLC without evidence of nodal disease in the preoperative staging who underwent lobectomy and radical lymphadenectomy. Patients who underwent lobectomy and systematic lymphadenectomy for early stage LUAD without evidence of nodal disease at the preoperative staging using NGS analysis for actionable molecular targets evaluation after surgery were evaluated. Exclusion criteria included the neoadjuvant treatment, incomplete resection and no adherence to preoperative guidelines. A total of 359 patients were included in the study. 172 patients were female, and the median age was 68 (61–72). The variables that showed a significant correlation with the upstaging rate at the univariate analysis were the ALK rearrangement, the number of resected lymph nodes and the diameter of the tumor. This result was confirmed in the multivariate analysis, with an OR of 8.052 (CI95% 3.123–20.763, p = 0.00001) for ALK rearrangement, 1.087 (CI95% 1.048–1.127, p = 0.00001) for the number of resected nodes and 1.817 (CI95% 1.214–2.719, p = 0.004) for cT status. Our results showed that in a homogeneous cohort of patients with clinical node early stage LUAD the ALK rearrangement, the number of resected lymph nodes and the tumor diameter can significantly predict nodal metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Immunological and Inflammatory Impact of Non-Intubated Lung Metastasectomy.
- Author
-
Mineo, Tommaso Claudio, Sellitri, Francesco, Vanni, Gianluca, Gallina, Filippo Tommaso, and Ambrogi, Vincenzo
- Subjects
METASTASIS ,VIDEO-assisted thoracic surgery ,GENERAL anesthesia ,LYMPHOCYTES ,DISEASES ,METASTASECTOMY - Abstract
Background: We hypothesized that video-assisted thoracic surgery (VATS) lung metastasectomy under non-intubated anesthesia may have a lesser immunological and inflammatory impact than the same procedure under general anesthesia. Methods: Between December 2005 and October 2015, 55 patients with pulmonary oligometastases (at the first episode) successfully underwent VATS metastasectomy under non-intubated anesthesia. Lymphocytes subpopulation and interleukins 6 and 10 were measured at different intervals and matched with a control group composed of 13 patients with similar clinical features who refused non-intubated surgery. Results: The non-intubated group demonstrated a lesser reduction of natural killer lymphocytes at 7 days from the procedure (p = 0.04) compared to control. Furthermore, the group revealed a lesser spillage of interleukin 6 after 1 (p = 0.03), 7 (p = 0.04), and 14 (p = 0.05) days. There was no mortality in any groups. Major morbidity rate was significantly higher in the general anesthesia group 3 (5%) vs. 3 (23%) (p = 0.04). The median hospital stay was 3.0 vs. 3.7 (p = 0.033) days, the estimated costs with the non-intubated procedure was significantly lower, even excluding the hospital stay. Conclusions: VATS lung metastasectomy in non-intubated anesthesia had significantly lesser impact on both immunological and inflammatory response compared to traditional procedure in intubated general anesthesia. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Minimally invasive hilum-mediastinal lymph nodes dissection for non-small cell lung cancer surgery: What is the future direction?
- Author
-
Gallina, Filippo Tommaso, Melis, Enrico, Forcella, Daniele, Mercadante, Edoardo, and Facciolo, Francesco
- Subjects
NON-small-cell lung carcinoma ,LUNG surgery ,LYMPHADENECTOMY ,ONCOLOGIC surgery ,VIDEO-assisted thoracic surgery ,NEEDLE biopsy - Published
- 2021
- Full Text
- View/download PDF
22. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis.
- Author
-
Spaggiari, Lorenzo, Bertolaccini, Luca, Facciolo, Francesco, Gallina, Filippo Tommaso, Rea, Federico, Schiavon, Marco, Margaritora, Stefano, Congedo, Maria Teresa, Lucchi, Marco, Ceccarelli, Ilaria, Alloisio, Marco, Bottoni, Edoardo, Negri, Giampiero, Carretta, Angelo, Cardillo, Giuseppe, Ricciardi, Sara, Ruffini, Enrico, Costardi, Lorena, Muriana, Giovanni, and Viggiano, Domenico
- Subjects
- *
NON-small-cell lung carcinoma , *PROGNOSIS - Abstract
• Oligometastatic NSCLC represents a category without a standard therapeutic approach. • In selected oligometastatic NSCLC, radical surgery seems to offer a good prognosis. • Treatment of selected synchronous oligometastatic NSCLC could be conducted safely. Oligometastatic Non-Small Cell Lung Cancer (NSCLC) patients represent a category without a standard therapeutic approach. However, in selected oligometastatic NSCLC, radical surgery seems to offer a good prognosis. This retrospective study aimed to analyse the long-term outcomes of synchronous oligometastatic patients treated with curative intent and identify the factors associated with better results and the proposal of a risk stratification system for classifying the synchronous oligometastatic NSCLC. The medical records of patients from 18 centres with pathologically diagnosed synchronous oligometastatic NSCLC were retrospectively reviewed. The inclusion criteria were synchronous oligometastatic NSCLC, radical surgical treatment of the primary tumour with or without neoadjuvant/adjuvant therapy and radical treatment of all metastatic sites. The Kaplan – Meier method estimated survivals. A stratified backward stepwise Cox regression model was assessed for multivariable survival analyses. 281 patients were included. The most common site of metastasis was the brain, in 50.89 % patients. Median overall survival was 40 months (95 % CI: 29–53). Age ≤65 years (HR = 1.02, 95 % CI: 1.00–1.05; p = 0.019), single metastasis (HR = 0.71, 95 % CI: 0.45–1.13; p = 0.15) and presence of contralateral lung metastases (HR = 0.30, 95 % CI: 0.15 – 0.62; p = 0.001) were associated with a good prognosis. The presence of pathological N2 metastases negatively affected survival (HR = 2.00, 95 % CI: 1.21–3.32; p = 0.0065). These prognostic factors were used to build a simple risk classification scheme. Treatment of selected synchronous oligometastatic NSCLC with curative purpose could be conducted safely and at acceptable 5-year survival levels, especially in younger patients with pN0 disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.